Whittier Trust CO Of Nevada Inc Vaxcyte, Inc. Transaction History
Whittier Trust CO Of Nevada Inc
- $4.34 Billion
- Q2 2025
A detailed history of Whittier Trust CO Of Nevada Inc transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 23 shares of PCVX stock, worth $1,002. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 23
-0.0%
Holding current value
$1,002
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
325Shares Held
139MCall Options Held
229KPut Options Held
160K-
Janus Henderson Group PLC London, X014.7MShares$640 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$523 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$522 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$433 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$262 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.59B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...